WASHINGTON — The Biden administration announced a $3.2 billion plan Thursday to build up the country’s supply of drugs to treat Covid-19 and future viral threats.
The plan, called the Antiviral Program for Pandemics, will spur clinical trials and the manufacturing of promising treatments for Covid-19, with the goal of gaining authorization from the Food and Drug Administration for some antivirals and making them available to the public within a year, the Department of Health and Human Services said in a statement.
Image: https://www.nbcnews.com – From Video